1999
DOI: 10.1074/jbc.274.39.27776
|View full text |Cite
|
Sign up to set email alerts
|

Molecular Cloning and Characterization of a Novel Human G-protein-coupled Receptor, EDG7, for Lysophosphatidic Acid

Abstract: response or cAMP accumulation was inhibited by pertussis toxin. In conclusion, the present study demonstrates that EDG7, a new member of the EDG family of G-protein-coupled receptors, is a specific LPA receptor that shows distinct properties from known cloned LPA receptors in ligand specificities, Ca 2؉ response, modulation of adenylyl cyclase, and MAP kinase activation.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

13
435
1

Year Published

2002
2002
2021
2021

Publication Types

Select...
6
2

Relationship

2
6

Authors

Journals

citations
Cited by 480 publications
(449 citation statements)
references
References 36 publications
13
435
1
Order By: Relevance
“…Furthermore, HB‐EGF, COX‐2, and Wnt4 as well as Bmp2 have been shown to be risk factors for sex hormone‐dependent diseases, such as prostatic hyperplasia, breast cancer, and ovarian cancer (Bentley et al , 1992; Ferrandina et al , 2002; Levin, 2003; Zong et al , 2012). Since LPA 3 is highly expressed in the prostate, mammary gland, and ovary (Bandoh et al , 1999), LPA 3 signaling might contribute to the progression of such diseases.…”
Section: Discussionmentioning
confidence: 99%
“…Furthermore, HB‐EGF, COX‐2, and Wnt4 as well as Bmp2 have been shown to be risk factors for sex hormone‐dependent diseases, such as prostatic hyperplasia, breast cancer, and ovarian cancer (Bentley et al , 1992; Ferrandina et al , 2002; Levin, 2003; Zong et al , 2012). Since LPA 3 is highly expressed in the prostate, mammary gland, and ovary (Bandoh et al , 1999), LPA 3 signaling might contribute to the progression of such diseases.…”
Section: Discussionmentioning
confidence: 99%
“…These responses are mediated by specific cell-surface G proteincoupled receptors, which are encoded by three cognate genes: lpa 1 /edg-2, lpa 2 /edg-4, and lpa 3 /edg-7 (Hecht et al, 1996;An et al, 1998;Contos and Chun, 1998;Bandoh et al, 1999;Chun, 1999;Chun et al, 1999;Fukushima et al, 2001). LPA 1 shares many downstream intracellular signaling pathways with LPA 2 , including inhibition of adenylyl cyclase (AC) and activation of phospholipase C (PLC) and the small GTPase Rho (Fukushima et al, 1998Ishii et al, 2000).…”
Section: Introductionmentioning
confidence: 99%
“…We also designed primers and tested these cell lines for the non-EDG LPA GPCRs LPA 4 and LPA 5 , as well as the intracellular LPA receptor and transcription factor PPARγ. PPARγ transcripts were present in RH7777 and DKO cells, but not in B103 cells [21].…”
Section: Receptor Profilingmentioning
confidence: 99%
“…The other EDG family members were cloned based upon sequence homology shortly thereafter, including two more LPA-specific receptors, EDG-4 [4] and EDG-7 [5], as well as four more S1P-specific receptors, EDG-3 [6] EDG-5 [7], EDG-6 [8], and EDG-8 [9]. In 2001 the IUPHAR proposed that the EDG nomenclature of the receptors be changed to reflect the receptors natural ligand and the order of its identification, giving the current receptor nomenclature of LPA 1 -3 and S1P [1][2][3][4][5] .…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation